SE9300937L - Komposition för oral administrering av peptider - Google Patents

Komposition för oral administrering av peptider

Info

Publication number: SE9300937L
Authority: SE; Sweden
Prior art keywords: pct; oral administration; spheres; date sep; sec
Prior art date: 1993-03-19

Application number

SE9300937A

Other languages

English (en)

Swedish (sv)

Other versions

SE9300937D0 (sv

Inventor

Anne Fjellestad-Paulsen

Original Assignee

Anne Fjellestad Paulsen

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-03-19

Filing date

1993-03-19

Publication date

1994-09-20

1993-03-19 Application filed by Anne Fjellestad Paulsen filed Critical Anne Fjellestad Paulsen

1993-03-19 Priority to SE9300937A priority Critical patent/SE9300937L/xx

1993-03-19 Publication of SE9300937D0 publication Critical patent/SE9300937D0/xx

1994-03-18 Priority to DE69419246T priority patent/DE69419246T2/de

1994-03-18 Priority to ES94911346T priority patent/ES2135570T3/es

1994-03-18 Priority to EP94911346A priority patent/EP0689452B1/en

1994-03-18 Priority to US08/525,584 priority patent/US5780434A/en

1994-03-18 Priority to PCT/SE1994/000244 priority patent/WO1994021286A1/en

1994-03-18 Priority to AU63889/94A priority patent/AU6388994A/en

1994-03-18 Priority to AT94911346T priority patent/ATE181508T1/de

1994-03-18 Priority to DK94911346T priority patent/DK0689452T3/da

1994-09-20 Publication of SE9300937L publication Critical patent/SE9300937L/xx

1999-09-22 Priority to GR990402412T priority patent/GR3031312T3/el

Links

108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
239000000203 mixture Substances 0.000 title abstract 2
102000004196 processed proteins & peptides Human genes 0.000 title abstract 2
238000000034 method Methods 0.000 abstract 2
102400000050 Oxytocin Human genes 0.000 abstract 1
101800000989 Oxytocin Proteins 0.000 abstract 1
XNOPRXBHLZRZKH-UHFFFAOYSA-N Oxytocin Natural products N1C(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CC(C)C)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C(C(C)CC)NC(=O)C1CC1=CC=C(O)C=C1 XNOPRXBHLZRZKH-UHFFFAOYSA-N 0.000 abstract 1
229940124158 Protease/peptidase inhibitor Drugs 0.000 abstract 1
GXBMIBRIOWHPDT-UHFFFAOYSA-N Vasopressin Natural products N1C(=O)C(CC=2C=C(O)C=CC=2)NC(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C1CC1=CC=CC=C1 GXBMIBRIOWHPDT-UHFFFAOYSA-N 0.000 abstract 1
108010004977 Vasopressins Proteins 0.000 abstract 1
102000002852 Vasopressins Human genes 0.000 abstract 1
KBZOIRJILGZLEJ-LGYYRGKSSA-N argipressin Chemical compound C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 KBZOIRJILGZLEJ-LGYYRGKSSA-N 0.000 abstract 1
239000006172 buffering agent Substances 0.000 abstract 1
230000003139 buffering effect Effects 0.000 abstract 1
239000002775 capsule Substances 0.000 abstract 1
239000011248 coating agent Substances 0.000 abstract 1
238000000576 coating method Methods 0.000 abstract 1
239000003937 drug carrier Substances 0.000 abstract 1
210000004051 gastric juice Anatomy 0.000 abstract 1
239000004615 ingredient Substances 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
XNOPRXBHLZRZKH-DSZYJQQASA-N oxytocin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@H](N)C(=O)N1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 XNOPRXBHLZRZKH-DSZYJQQASA-N 0.000 abstract 1
229960001723 oxytocin Drugs 0.000 abstract 1
239000000137 peptide hydrolase inhibitor Substances 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
239000007787 solid Substances 0.000 abstract 1
210000002784 stomach Anatomy 0.000 abstract 1
229960003726 vasopressin Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/095—Oxytocins; Vasopressins; Related peptides

Landscapes

Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)

SE9300937A 1993-03-19 1993-03-19 Komposition för oral administrering av peptider SE9300937L (sv)

Priority Applications (10)

Application Number	Priority Date	Filing Date	Title
SE9300937A SE9300937L (sv)	1993-03-19	1993-03-19	Komposition för oral administrering av peptider
DK94911346T DK0689452T3 (da)	1993-03-19	1994-03-18	Sammensætning til oral administration af peptider
US08/525,584 US5780434A (en)	1993-03-19	1994-03-18	Composition for oral administration of peptides
ES94911346T ES2135570T3 (es)	1993-03-19	1994-03-18	Composicion para la administracion oral de peptidos.
EP94911346A EP0689452B1 (en)	1993-03-19	1994-03-18	Composition for oral administration of peptides
DE69419246T DE69419246T2 (de)	1993-03-19	1994-03-18	Zusammensetzungen zur oralen verabreichung von peptiden
PCT/SE1994/000244 WO1994021286A1 (en)	1993-03-19	1994-03-18	Composition for oral administration of peptides
AU63889/94A AU6388994A (en)	1993-03-19	1994-03-18	Composition for oral administration of peptides
AT94911346T ATE181508T1 (de)	1993-03-19	1994-03-18	Zusammensetzungen zur oralen verabreichung von peptiden
GR990402412T GR3031312T3 (en)	1993-03-19	1999-09-22	Composition for oral administration of peptides

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
SE9300937A SE9300937L (sv)	1993-03-19	1993-03-19	Komposition för oral administrering av peptider

Publications (2)

Publication Number	Publication Date
SE9300937D0 SE9300937D0 (sv)	1993-03-19
SE9300937L true SE9300937L (sv)	1994-09-20

Family

ID=20389308

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SE9300937A SE9300937L (sv)	1993-03-19	1993-03-19	Komposition för oral administrering av peptider

Country Status (10)

Country	Link
US (1)	US5780434A (da)
EP (1)	EP0689452B1 (da)
AT (1)	ATE181508T1 (da)
AU (1)	AU6388994A (da)
DE (1)	DE69419246T2 (da)
DK (1)	DK0689452T3 (da)
ES (1)	ES2135570T3 (da)
GR (1)	GR3031312T3 (da)
SE (1)	SE9300937L (da)
WO (1)	WO1994021286A1 (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9325445D0 (en)	1993-12-13	1994-02-16	Cortecs Ltd	Pharmaceutical formulations
SE9400918L (sv) *	1994-03-18	1995-09-19	Anne Fjellstad Paulsen	Stabiliserad komposition för oral administrering av peptider
US8765177B2 (en) *	1997-09-12	2014-07-01	Columbia Laboratories, Inc.	Bioadhesive progressive hydration tablets
US7153845B2 (en) *	1998-08-25	2006-12-26	Columbia Laboratories, Inc.	Bioadhesive progressive hydration tablets
WO2002038609A2 (en)	2000-11-10	2002-05-16	Proteopharma Aps	Apolipoprotein conjugates
GB0210397D0 (en) *	2002-05-07	2002-06-12	Ferring Bv	Pharmaceutical formulations
PT1530967E (pt) *	2003-11-13	2006-09-29	Ferring Bv	Embalagem blister e uma forma de dosagem solida que compreende desmopressina.
EP2417986A1 (en)	2004-11-22	2012-02-15	Anadis Ltd.	Bioactive compositions
JP5276982B2 (ja)	2005-08-26	2013-08-28	ボードオブトラスティーズオブザレランドスタンフォードジュニアユニバーシティ	オキシトシンの投与による頭痛の処置のための方法
SE0600482L (sv) *	2006-03-02	2006-11-14	Ferring Int Ct Sa	Farmaceutisk sammansättning innefattande desmopressin, kiseldioxid och stärkelse
US20080260820A1 (en) *	2007-04-19	2008-10-23	Gilles Borrelly	Oral dosage formulations of protease-resistant polypeptides
ES2319054B1 (es)	2007-08-06	2010-02-12	Gp Pharm S.A.	Composicion farmaceutica oral de desmopresina.
WO2009021007A1 (en)	2007-08-06	2009-02-12	Serenity Pharmaceuticals Corporation	Methods and devices for desmopressin drug delivery
US11963995B2 (en)	2008-05-21	2024-04-23	Ferring B.V.	Methods comprising desmopressin
NO3085381T3 (da) *	2008-05-21	2018-09-15
US20100286045A1 (en)	2008-05-21	2010-11-11	Bjarke Mirner Klein	Methods comprising desmopressin
CA2765221C (en)	2009-06-18	2017-10-03	Allergan, Inc.	Safe desmopressin administration
PL3242676T3 (pl)	2015-01-07	2024-07-15	Tonix Pharma Limited	Preparaty oksytocyny zawierające magnez i sposoby ich stosowania
HRP20250215T1 (hr)	2016-04-12	2025-06-20	Tonix Pharma Limited	Formulacije oksitocina koje sadrže magnezij i postupci upotrebe

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4139504A (en) *	1977-06-16	1979-02-13	Coy David Howard	Novel nonapeptides, intermediates therefor, and compositions and methods employing said nonapeptides
IL68769A (en) *	1983-05-23	1986-02-28	Hadassah Med Org	Pharmaceutical compositions containing insulin for oral administration
JPS608225A (ja) *	1983-06-29	1985-01-17	Kowa Co	腸管吸収医薬組成物
SE8306367L (sv) *	1983-11-18	1985-05-19	Ferring Ab	Antidiuretiskt verkande farmaceutiskt preparat
US4849227A (en) *	1986-03-21	1989-07-18	Eurasiam Laboratories, Inc.	Pharmaceutical compositions
AU637316B2 (en) *	1988-01-28	1993-05-27	Eastman Kodak Company	Polypeptide compounds having growth hormone releasing activity
DE3919982A1 (de) *	1989-06-19	1990-12-20	Liedtke Pharmed Gmbh	Orale lipidarzneiform
JP3009911B2 (ja) *	1989-06-28	2000-02-14	エーザイ株式会社	ペプチド又は蛋白の内服用新規製剤
JPH04364131A (ja) *	1991-04-03	1992-12-16	Sanwa Kagaku Kenkyusho Co Ltd	易吸収性モチリン製剤
US5206219A (en) *	1991-11-25	1993-04-27	Applied Analytical Industries, Inc.	Oral compositions of proteinaceous medicaments

1993
- 1993-03-19 SE SE9300937A patent/SE9300937L/xx not_active Application Discontinuation
1994
- 1994-03-18 AU AU63889/94A patent/AU6388994A/en not_active Abandoned
- 1994-03-18 DK DK94911346T patent/DK0689452T3/da active
- 1994-03-18 ES ES94911346T patent/ES2135570T3/es not_active Expired - Lifetime
- 1994-03-18 DE DE69419246T patent/DE69419246T2/de not_active Expired - Fee Related
- 1994-03-18 EP EP94911346A patent/EP0689452B1/en not_active Expired - Lifetime
- 1994-03-18 AT AT94911346T patent/ATE181508T1/de not_active IP Right Cessation
- 1994-03-18 WO PCT/SE1994/000244 patent/WO1994021286A1/en not_active Ceased
- 1994-03-18 US US08/525,584 patent/US5780434A/en not_active Expired - Fee Related
1999
- 1999-09-22 GR GR990402412T patent/GR3031312T3/el unknown

Also Published As

Publication number	Publication date
US5780434A (en)	1998-07-14
EP0689452B1 (en)	1999-06-23
WO1994021286A1 (en)	1994-09-29
AU6388994A (en)	1994-10-11
DK0689452T3 (da)	1999-12-13
DE69419246T2 (de)	2000-01-20
GR3031312T3 (en)	1999-12-31
ES2135570T3 (es)	1999-11-01
ATE181508T1 (de)	1999-07-15
EP0689452A1 (en)	1996-01-03
DE69419246D1 (de)	1999-07-29
SE9300937D0 (sv)	1993-03-19

Legal Events

Date	Code	Title	Description
2000-08-14	NAV	Patent application has lapsed	Ref document number: 9300937-1

Publication	Publication Date	Title
FI114688B (fi)	2004-12-15	Stabiloitu koostumus peptidien antamiseksi suun kautta
DK0689452T3 (da)	1999-12-13	Sammensætning til oral administration af peptider
ATE81287T1 (de)	1992-10-15	Am zielorgan wirkendes enterales abgabesystem.
KR100197465B1 (en)	1999-06-15	Rapidly disintegratable multiparticulate tablet
EP1275381A4 (en)	2007-05-02	SOLID COATED PREPARATIONS WITH TEMPERATURE RELEASE FOR ORAL ADMINISTRATION
YU58902A (sh)	2005-11-28	Oralne formulacije opijatnog agonista otporne na mehaničke, termičke i/ili hemijske promene fizičkih osobina doznog oblika
ZA952169B (en)	1995-09-26	Pharmaceutical compositions
MY125662A (en)	2006-08-30	Pharmaceutical formulations containing darifenacin
KR850700212A (ko)	1985-12-26	서방성 약제학적 캼셀제
SK169999A3 (en)	2000-07-11	Controlled release pharmaceutical preparation with ace inhibitor as active agent
TW200517127A (en)	2005-06-01	Novel composition
RU2449796C9 (ru)	2007-10-27	Фармацевтическая комбинация этинилэстрадиола и дроспиренона для использования в качестве контрацептива
HK1000904A (en)	1998-05-08	Composition for oral administration of peptides
HK1000905A (en)	1998-05-08	Stabilized composition for oral administration of peptides
GB2405094A (en)	2005-02-23	Pharmaceutical composition for controlled drug delivery system
IL41524A (en)	1976-03-31	Pharmaceutical preparations containing the product of proline